Insensitivity to Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs and γ-Secretase Inhibitors Is Common among Aggressive Presenilin-1 Mutations

This publication has 46 references indexed in Scilit:

• Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
  EMBO Reports, 2006
• Signal Peptide Peptidase: Biochemical Properties and Modulation by Nonsteroidal Antiinflammatory Drugs
  Biochemistry, 2006
• The GxGD Motif of Presenilin Contributes to Catalytic Function and Substrate Identification of γ-Secretase
  Journal of Neuroscience, 2006
• Selected Non-steroidal Anti-inflammatory Drugs and Their Derivatives Target γ-Secretase at a Novel Site
  Journal of Biological Chemistry, 2004
• Purification and Characterization of the Human γ-Secretase Complex
  Biochemistry, 2004
• Studies of Aβ Pharmacodynamics in the Brain, Cerebrospinal Fluid, and Plasma in Young (Plaque-Free) Tg2576 Mice Using the γ-Secretase Inhibitor N2-[(2 S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7 S)-5-methyl-6-oxo-6,7-dihydro-5 H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575)
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• The Mechanism of γ-Secretase
  Published by Elsevier ,2003
• Catalytic Site-Directed γ-Secretase Complex Inhibitors Do Not Discriminate Pharmacologically between Notch S3 and β-APP Cleavages
  Biochemistry, 2003
• Familial Alzheimer Disease-linked Presenilin 1 Variants Enhance Production of Both Aβ1–40 and Aβ1–42 Peptides That Are Only Partially Sensitive to a Potent Aspartyl Protease Transition State Inhibitor of “γ-Secretase”
  Published by Elsevier ,2003
• Linear Non-competitive Inhibition of Solubilized Human γ-Secretase by Pepstatin A Methylester, L685458, Sulfonamides, and Benzodiazepines
  Journal of Biological Chemistry, 2002